Paola G.
- Country
- Italy
- Department
- Neurologia II - Neuro Oncology
Research Overview
- ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (The ACTION Study)
- Evaluation of Safety and Efficacy of L19TNF and Lomustine in Patients with Glioblastoma at First Progression
- Phase I/II Evaluation of NMS-03305293 and Temozolomide in Adult Patients with Recurrent Glioblastoma
Data & Insights
Has run more than one trial at 10 of 47 partner sites.
Specializations
Neuro-Oncology Focus
This investigator specializes in treating various types of brain tumors, with particular expertise in aggressive and rare manifestations. Their research encompasses glioblastoma and different grades of meningioma.
- Recurrent Glioblastoma Treatment
- Grade 2 and 3 Meningioma Management
- H3 K27M-mutant Diffuse Glioma
Their work includes evaluating innovative therapeutic approaches for patients with progressive brain tumors.
Advanced Therapeutic Applications
The investigator focuses on developing treatment strategies for recurrent brain tumors, incorporating both established and experimental therapeutic agents.
- Targeted Antibody-Cytokine Therapies
- Novel Drug Combinations
- Post-Radiotherapy Interventions
Their research explores multiple therapeutic modalities for patients who have progressed after standard treatments.
Treatment Innovation
The investigator's work centers on evaluating progression-free survival in brain tumor patients through various therapeutic interventions.
- Molecular Targeted Therapies
- Personalized Treatment Approaches
- Multi-Modal Treatment Strategies
Their research encompasses both early-phase and advanced clinical investigations in neuro-oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.